AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CEFTAROLINE FOSAMIL
3 registrations across 3 African markets— 2 active
Markets with CEFTAROLINE FOSAMIL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Zinforo Powder# Powder for infusion | 🇳🇬Nigeria | AstraZeneca Nigeria Limited | active | Dec 2027 |
| ZINFORO Poudre pour solution pour perfusion / 600 MG | 🇹🇳Tunisia | PFIZER Ireland Pharmaceuticals | expired | Mar 2020 |
| ZINFORO 600 mg | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | active | Jan 1900 |
CEFTAROLINE FOSAMIL in Africa — Regulatory Overview
CEFTAROLINE FOSAMIL is registered across 3 African markets with 3 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Tunisia, South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 3 registrations, 2 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.